NEW YORK, Nov. 17, 2017 /PRNewswire/ --
If you want a Stock Review on RMD, SNN, SYK, or ZBH then come over to http://dailystocktracker.com/register/
San Diego, California headquartered ResMed Inc.'s stock finished Thursday's session 0.87% higher at $84.98 with a total trading volume of 649,972 shares, which was above its three months average volume of 613.18 thousand shares. The Company's shares have advanced 16.30% in the previous three months, 47.13% over the past twelve months, and 36.95% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 6.64% and 14.11%, respectively. Additionally, shares of ResMed, which develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases, have a Relative Strength Index (RSI) of 64.62. Sign up and read the free research report on RMD at: http://dailystocktracker.com/registration/?symbol=RMD
Smith & Nephew
On Thursday, shares in London, the UK headquartered Smith & Nephew PLC recorded a trading volume of 321,483 shares. The stock ended the session 1.32% higher at $35.97. The Company's shares have advanced 31.42% over the last twelve months and 19.58% on an YTD basis. The stock is trading above its 200-day moving average by 4.85%. Moreover, shares of the Company, which designs, develops, and sells medical devices worldwide, have an RSI of 41.84. The complimentary research report on SNN can be downloaded at: http://dailystocktracker.com/registration/?symbol=SNN
Kalamazoo, Michigan headquartered Stryker Corp.'s shares closed the day 1.09% higher at $156.48. The stock recorded a trading volume of 1.24 million shares, which was above its three months average volume of 1.20 million shares. The Company's shares have gained 43.05% over the last twelve months and 30.61% since the start of the year. The stock is trading above its 50-day and 200-day moving averages by 5.66% and 12.00%, respectively. Additionally, shares of Stryker, which together with its subsidiaries, operates as a medical technology company, have an RSI of 61.51.
On November 16th, 2017, research firm Robert W. Baird upgraded the Company's stock rating from 'Neutral' to 'Outperform' while revising its previous target price from $161 a share to $173 a share. Register for free on DailyStockTracker.com and access the latest report on SYK at: http://dailystocktracker.com/registration/?symbol=SYK
Zimmer Biomet Holdings
Shares in Warsaw, Indiana headquartered Zimmer Biomet Holdings Inc. finished 1.04% higher at $112.24. The stock recorded a trading volume of 1.57 million shares, which was above its three months average volume of 1.34 million shares. The Company's shares have advanced 11.26% over the last twelve months. The stock is trading below its 50-day moving average by 3.69%. Furthermore, shares of Zimmer Biomet, which together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, Middle-East, Africa, and Asia/Pacific, have an RSI of 43.20.
On November 09th, 2017, research firm Edward Jones upgraded the Company's stock rating from 'Hold' to 'Buy'. Get free access to your research report on ZBH at: http://dailystocktracker.com/registration/?symbol=ZBH
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://dailystocktracker.com/disclaimer/
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
View original content:http://www.prnewswire.com/news-releases/stocks-under-scanner-in-the-medical-equipment-space----resmed-smith--nephew-stryker-and-zimmer-biomet-300558476.html
Subscribe to our Free Newsletters!
Breathing in unclean air due to increasing air pollution could cause kidney damage with resultant ...
Benign prostatic hyperplasia or enlarged prostate is a noncancerous condition observed in men above ...
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...View All